Laura A. Williams sold ARDX shares eight times on the open market over the past year, totaling nearly $1 million, with her most recent sale on February 20, 2026. Her sales rank 4,970th among 11,678 insiders, below the average of $8.6 million per seller and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | ARDELYX, INC. | $ARDX | Williams Laura A | See Remarks | S | Common Stock | 984 | $5.71 | 436,082.0000 | 245,247,427 | 0.23% | 0.00% |
| Feb. 20, 2026 | ARDELYX, INC. | $ARDX | Williams Laura A | See Remarks | S | Common Stock | 7192 | $5.87 | 437,066.0000 | 245,247,427 | 1.62% | 0.00% |
| Jan. 23, 2026 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | A | Common Stock | 82695 | $0.00 | 444,258.0000 | 242,974,306 | 22.87% | 0.03% |
| Jan. 23, 2026 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | A | Stock Option (Right to Buy) | 124040 | $0.00 | 124,040.0000 | 242,974,306 | 9999.99% | 0.05% |
| Jan. 8, 2026 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | M | Common Stock | 50000 | $0.99 | 409,896.0000 | 242,974,306 | 13.89% | 0.02% |
| Jan. 8, 2026 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | M | Stock Option (Right to Buy) | 0 | $0.00 | 62,000.0000 | 242,974,306 | 0.00% | 0.00% |
| Jan. 8, 2026 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | S | Common Stock | 50000 | $6.98 | 361,563.0000 | 242,974,306 | 12.15% | 0.02% |
| Nov. 21, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | S | Common Stock | 6426 | $5.54 | 359,896.0000 | 242,974,306 | 1.75% | 0.00% |
| Aug. 26, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | S | Common Stock | 50000 | $6.12 | 396,322.0000 | 238,356,222 | 11.20% | 0.02% |
| Aug. 26, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | M | Common Stock | 50000 | $0.99 | 446,322.0000 | 238,356,222 | 12.62% | 0.02% |
| Aug. 26, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 112,000.0000 | 238,356,222 | 30.86% | 0.02% |
| Aug. 26, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | S | Common Stock | 30000 | $6.12 | 366,322.0000 | 238,356,222 | 7.57% | 0.01% |
| Aug. 21, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Patient Officer | S | Common Stock | 6261 | $5.93 | 396,322.0000 | 238,356,222 | 1.56% | 0.00% |
| May 20, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 6421 | $4.08 | 402,583.0000 | 238,356,222 | 1.57% | 0.00% |
| Feb. 25, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | A | Common Stock | 105200 | $0.00 | 409,004.0000 | 238,356,222 | 34.63% | 0.04% |
| Feb. 25, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | A | Stock Option (Right to Buy) | 157700 | $0.00 | 157,700.0000 | 238,356,222 | 9999.99% | 0.07% |
| Feb. 20, 2025 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 4941 | $5.62 | 303,804.0000 | 238,356,222 | 1.60% | 0.00% |
| Nov. 20, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 7366 | $4.79 | 308,745.0000 | 0 | 2.33% | 0.00% |
| Aug. 20, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 7412 | $5.86 | 314,740.0000 | 0 | 2.30% | 0.00% |
| June 5, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 100000 | $7.13 | 322,152.0000 | 0 | 23.69% | 0.00% |
| June 5, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 251,000.0000 | 0 | 28.49% | 0.00% |
| June 5, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 45000 | $7.12 | 422,152.0000 | 0 | 9.63% | 0.00% |
| June 5, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | M | Common Stock | 100000 | $2.75 | 467,152.0000 | 0 | 27.24% | 0.00% |
| May 21, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 4794 | $7.81 | 367,152.0000 | 0 | 1.29% | 0.00% |
| May 3, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | M | Common Stock | 30000 | $0.99 | 410,138.0000 | 0 | 7.89% | 0.00% |
| May 3, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 39949 | $8.35 | 370,189.0000 | 0 | 9.74% | 0.00% |
| May 3, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 162,000.0000 | 0 | 15.63% | 0.00% |
| Feb. 20, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | S | Common Stock | 4803 | $8.75 | 380,138.0000 | 0 | 1.25% | 0.00% |
| Jan. 16, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | A | Common Stock | 118750 | $0.00 | 384,941.0000 | 0 | 44.61% | 0.00% |
| Jan. 16, 2024 | ARDELYX, INC. | $ARDX | Williams Laura A | Chief Medical Officer | A | Stock Option (Right to Buy) | 152127 | $0.00 | 152,127.0000 | 0 | 9999.99% | 0.00% |